ADMS
Adamas Pharmaceuticals, Inc.
ADMS
ADMS
Delisted
ADMS was delisted on the 23rd of November, 2021.
72 hedge funds and large institutions have $146M invested in Adamas Pharmaceuticals, Inc. in 2021 Q1 according to their latest regulatory filings, with 19 funds opening new positions, 26 increasing their positions, 17 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
72
Holders Change
+8
Holders Change %
+12.5%
% of All Funds
1.27%
Holding in Top 10
2
Holding in Top 10 Change
+2
Holding in Top 10 Change %
%
% of All Funds
0.04%
New
19
Increased
26
Reduced
17
Closed
11
Calls
$830K
Puts
$689K
Net Calls
+$141K
Net Calls Change
+$191K
Top Buyers
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
76
Connor, Clark & Lunn Investment Management (CC&L)
Vancouver,
British Columbia, Canada
| – | -$106K | -24,595 | Closed |
|
77
Capstone Investment Advisors
New York
| – | -$66K | -15,248 | Closed |
|
78
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| – | -$60K | -13,926 | Closed |
|
|
AGM
79
Alpine Global Management
New York
| – | -$54K | -12,581 | Closed |
|
80
Citigroup
New York
| – | -$43K | -10,000 | Closed |
|
81
Russell Investments Group
London,
United Kingdom
| – | -$20K | -4,814 | Closed |
|
82
Group One Trading
Chicago,
Illinois
| – | -$5K | -1,044 | Closed |
|